Skip to main content

Table 2 Therapy characteristics and disease outcome

From: Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy

Characteristic

N (%)

Characteristic

N (%)

Type of breast surgery

 

Disease relapse

 

Radical mastectomy

36 (44.44)

Yes

10 (12.35)

Breast conserving surgery

41 (50.62)

No

71 (87.65)

Other

4 (4.94)

  
  

First relapse site

 
  

Locoregional relapse

4 (4.94)

Adjuvant systemic therapy

 

Lung

3 (3.7)

Yes

81 (100)

Liver

1 (1.23)

No

Bones

4 (4.94)

  

Brain

1 (1.23)

  

Contralateral BC

1 (1.23)

Adjuvant hormonal therapy

81 (100)

Total

10 (12.35)

TAM

70 (86.42)

  

TAM + GOSERELIN

2 (2.47)

Patients’ outcome

 

AI

9 (11.11)

Dead

7 (8.64)

  

Alive

74 (91.36)

Adjuvant RT

 

Relevant events a

 

Yes

45 (55.56)

Yes

15 (18.52)

No

36 (44.44)

No

66 (81.48)

  1. aRelevant events: development of loco-regional recurrence and/or distant metastases and/or contralateral breast cancer and/or non-breast primary cancer and/or death from any cause